Viagra Is Good for the Heart
Copyright 2005 Daily News Central
Viagra (Sildenafil citrate), which millions of men take for
erectile dysfunction (ED), reduces the effects of hormonal
stress on the heart by half, according to a study published
online in the journal Circulation.
Viagra causes genital blood vessels to expand, which helps in
maintaining an erection. Recent research also has pointed to its
potential usefulness in treating pulmonary hypertension. Prior
to the latest findings by a team of Johns Hopkins researchers,
it was thought to have little effect on the heart.
Viagra, or sildenafil, blunts the strengthened heart beat caused
by chemically induced stress, according to study senior author
and cardiologist David Kass, MD, a professor at the Johns
Hopkins University School of Medicine and its Heart Institute.
It thereby lessens both the excess amount of blood and the force
used to pump it to the body.
"Sildenafil effectively puts a 'brake' on chemical stimulation
of the heart," says Kass.
Prevents and Reverses Effects of High BP
These findings are believed to be the first confirmation in
humans that Viagra has a direct effect on the heart. In earlier
research, Kass and his team observed a similar effect in mice;
Sildenafil blocked the short-term effects of hormonal stress in
the heart.
Related studies by the group show that sildenafil also prevents
and reverses the long-term effects of chronic high blood
pressure on the heart.
Sildenafil reversed the negative effects on heart muscle
weakened by heart failure and enlargement -- a condition called
hypertrophy -- in mouse experiments Kass and his team carried
out earlier this year. They reported their results in the
journal Nature Medicine.
"But we had no firm evidence as to whether or how this therapy
might work in the human heart," says Kass. "Our latest research
provides firm evidence this drug does indeed have an important
impact on the heart."
Increased Heartbeat Was Slowed
Thirty-five healthy men and women, with an average age of 30 and
no previous signs of coronary artery disease, participated in
the six-month Johns Hopkins study. Within a three-hour
timeframe, each participant received two separate injections of
dobutamine (5 micrograms per kilogram for five minutes), a
synthetic, adrenaline-like chemical that increases heart rate
and pumping strength.
Between injections, study participants were assigned randomly to
a group that was treated with sildenafil (100 milligrams taken
orally) or to a group given a sugar pill placebo. All
participants then were given the second dobutamine injection to
see what effects sildenafil or placebo had on the heart.
Measurements of heart function were made before and after each
injection. These included blood pressure readings,
electrocardiograms and echocardiograms. Blood samples confirmed
relatively equal levels of sildenafil and other enzymes.
Each dobutamine injection stimulated heart function, increasing
heart rate and the force of each heartbeat used to pump blood
throughout the body, results showed.
"This stimulation is similar to the way the nervous system
normally increases heart function when triggered by emotional or
exercise stress, or in diseases such as heart failure," notes
Kass.
After the first injection of dobutamine, the force of heart
contraction increased by 150 percent in both groups. In the
placebo group, this increase repeated itself after the second
injection. However, in the group treated with sildenafil, the
increased heartbeat was slowed by 50 percent, resulting in a
smaller increase in blood flow and blood pressure generated by
the heart in response to chemical stimulation.
Between injections, heart function was not altered in the
sildenafil group, demonstrating the absence of adverse side
effects on the resting human heart.
Stops PDE5A Action
"Knowing more about the effects of sildenafil on heart function
will allow for safer evaluation of its use as a treatment for
heart problems," says Kass.
"Our results set the stage for further studies of sildenafil's
immediate and long-term effects on the heart and its ability to
modify other neurohormonal and stress stimuli, including
adrenaline and hypertension," he adds.
While the precise biological actions of sildenafil in the heart
are not fully understood, the drug is known to work by stopping
the action of an enzyme, called phosphodiesterase 5 (PDE5A),
Kass explains. This enzyme is involved in the breakdown of a key
molecule, cyclic GMP, which helps control stresses and limit
overgrowth in the heart.
PDE5A is also the biological pathway that sildenafil blocks in
the penis to prevent the relaxation of blood vessels and thus
maintain erections.